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Hydrochlorothiazide is a diuretic drug used for mild to moderate hypertension were classified in Class II 
BSC. The purpose of this study was to explore the formation of hydrochlorothiazide-para-aminobenzoic acid 
cocrystal by solvent evaporation method. Cocrystals are prepared with a molar ratio of 1:0; 1:1; 1:2; and 2:1 
between hydrochlorothiazide and para-aminobenzoic acid. The cocrystals were characterized by Scanning Electron 
Microscopy (SEM), X-ray Diffractometry (XRD), Differential Scanning Calorimetry (DSC), and Fourier Transform 
Infrared (FT-IR) spectrophotometer. The hydrochlorothiazide-para-aminobenzoic acid cocrystal has new crystalline 
peaks at 2θ of 14.904o; 15.41o; 25.553o; 26.5o; 29.844o; 31.083o indicating the formation of a new crystalline phase. 
The cocrystal showed the melting point at 188.57oC which is different from the initial components. The FTIR 
spectra of cocrystal showed the shifting of absorption peaks of groups of initial components indicating of formation 
of hydrochlorothiazide-para-aminobenzoic acid cocrystal through intermolecular hydrogen bond interactions 
between amine/sulfonamide group and carboxyl group. 
 




Hydrochlorothiazide is a diuretic drug used 
for mild to moderate hypertension. According 
to BCS (Biopharmaceutical Classification 
System), hydrochlorothiazide is the II class of 
drugs, namely drugs with low solubility and 
high permeability (Sanphui, et al., 2015);, 
causes poor oral absorption. Because it is 
poorly soluble, hydrochlorothiazide can cause 
problem of limited dissolution and absorption 
rates and therefore, improvement of solubility 
is needed to increase absorption and 
bioavailability. Hydrochlorothiazide (6-
chloro-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-
benzothiadiazine-7-sulfonamide) is a weak 
basic compound ( pKa =7.9) (PubChem, 
2021). This is consistent with the FDA's 
statement that another advantage of co-
crystals is that they provide a variety of solid-
state forms for APIs that lack ionizable 
functional groups, which are prerequisites for 
salt formation (FDA, 2018).  
Increasing the solubility of an active 
pharmaceutical ingredient can be done 
through modification of the crystal structure, 
such as cocrystal formation techniques with 
suitable co-formers (Karimi-Jafari, Padrela, 
Walker, & Croker, 2018). Cocrystals are a 
class of multicomponent solids consisting two 
or more different molecular components 
(Gadade & Pekamwar, 2016) in a single 
homogenous crystalline phase with well-
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defined stoichiometry (Kuminek, Cao, Rocha, 
Cardoso, & Rodríguez-Hornedo, 2016), 
which is solid at ambient temperature, with 
the intermolecular interactions in the unique 
crystal lattice resulting in weak forces (non-
covalent and non-ionic), such as hydrogen 
bonds, van der Waals bonds (Karagianni, 
Malamatari, & Kachrimanis, 2018); (Cao, 
Amidon, Rodríguez-Hornedo, & Amidon, 
2018). 
The cocrystal design can be done using a 
supramolecular heterosynthon approach in the 
presence of functional groups in API 
molecules and different co-formers. 
Supramolecular heterosynthons can be 
formed from carboxylic acids - amides, 
carboxylic acids - aromatic nitrogen, 
alcohols-aromatic nitrogen, and alcohol-
amines (Duggirala, Perry, Almarsson, & 
Zaworotko, 2016). The formation of 
cocrystals of hydrochlorothiazide can carried 
out by using para-aminobenzoic acid as a 
conformer, because chemically para-
aminobenzoic acid has a carboxyl and amine 
group that can interact trough hydrogen bonds 
with the primary and secondary sulphonamide 
groups of hydrochlorothiazide.   
Various methods of cocrystal formation 
have been reported, and they are divided into 
solution-based co-crystallization and solid-
based co-crystallization (Guo, Sun, Chen, & 
Cai, 2021). Co-crystallization with solvent 
evaporation technique is one of the 
applications of solution-based co-
crystallization. In this method, the cocrystal 
components provided in suitable 
stoichiometric ratios are dissolved together in 
a suitable solvent and then allowed to 
evaporate the solvent completely (Weyna, 
Shattock, Vishweshwar, & Zaworotko, 2009) 
(Winantari, Setyawan, Siswodihardjo, & 
Soewandhi, 2017) . 
 The objective of this study was to explore 
co-crystallization of hydrochlorothiazide–
para-aminobenzoic acid by solvent 
evaporation technique. Cocrystals were made 
using methanol as solvent and allowed at 
room temperature to evaporate the solvent 
completely. Cocrystal and their constituent 
component were characterized by X-Ray 
Diffraction (XRD) and Differential scanning 
calorimetry (DSC) instruments. The 
formation of hydrogen bonds was observed 
with an FTIR spectrophotometer to determine 
the intensity changes of the peaks spectra of 
the functional groups involved in hydrogen 
bonds formation. Cocrystal morphology 
 
Fig. 1 a. Hydrochlorothiazide, b. Para aminobenzoic acid 
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observations were carried out using scanning 
electron microscope (SEM).  
MATERIAL AND METHODS  
Chemicals and Instrument  
Hydrochlorothiazide were purchased from 
Changzou Pharmaceutical Factory, Para 
Aminobenzoic acid were purchased from Sigma 
Aldrich. Methanol (p.a) from Merck. 
The Instruments use were analytical balance 
(Kern), Differential Scanning Calorimetry/DSC 
(Perkin Elmer DSC 4000), Fourier Transform 
Infrared/FT-IR (SHIMADZU IR Prestige), 
Scanning Electron Microscope/SEM 
(BRUKER), magnetic stirrer (Heidolph), X-Ray 
Difractometry/XRD (RIGAKU Mini FlexII). 
Co-crystal Formation 
Hydrochlorothiazide-para-aminobenzoic 
acid co-crystals were prepared in molar ratios 
of 1:0, 1:1, 1:2 and 2:1. Co-crystallization 
was carried out by solvent evaporation 
method (Kothur, Swetha, & Bondili, 2012). 
Hydrochlorothiazide and Para-aminobenzoic 
acid were put into a beaker and 50 mL of 
methanol added. The mixture was stirred with 
a magnetic stirrer at 60°C of temperature and 
100 rpm for 1 hour, then transferred to an 
evaporating dish and allowed to stand at room 
temperature until the solvent evaporated 
completely. The cocrystals obtained were 
collected for further testing. 
Characterization of Co-crystal 
Scanning Electron Microscope (SEM) 
Microscopic observations of the 
morphology of the raw material and 
cocrystals of hydrochlorothiazide – para-
aminobenzoic acid was carried out by). A 
small number of samples were placed in a 
sample holder made of aluminum and coated 
with gold palladium (Au) with a thickness of 
10 nm. The sample then observed at various 
magnifications. Voltages were set at 10.15 
and 20 kV and current to 0.4 mA using 
Det.BSE and SE. 
X-Ray Diffraction 
X-ray diffraction patterns of 
hydrochlorothiazide and cocrystals were 
carried out using the X-Ray Difractometry 
(XRD) system with Cu as the stain material 
and graphite monochromator, operated at a 
voltage of 30 kV, current 15 mA. Scanning is 
carried out over an angle range of 10-70° and 
scanning speed of 4° per minute. 
Differential Scanning Calorimetry 
DSC analysis of hydrochlorothiazide and 
cocrystals was carried out using the DSC 
Perkin Elmer 4000. The samples (10-20 mg) 
were put into a crucible, with nitrogen as pure 
gas and flow rate of 20 ml/min. Heating at 
30-400°C with a heating rate of 20°C per 
minute. 
Fourier Transform Infrared Spectroscopy 
Infrared spectra of hydrochlorothiazide 
and cocrystals were obtained by means of 
Fourier Transform Infra-Red (FTIR) 
Spectrophotometry. Sample preparation was 
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carried out by pellet technique using the KBr 
reflectance diffusion method (sample 
concentration of 2 mg in 20 mg KBr). The 
measurement was recorded over range 4500-
350 cm-1. 
RESULTS AND DISCUSSION 
Scanning electron microscope (SEM) 
Each crystalline material has a hidden 
atomic structure, which on X-ray irradiation 
causes constructive and destructive 
interference of the scattered X-ray beams, 
resulting in a unique diffraction pattern that 
presents several sharp points, known as Bragg 
diffraction peaks (Kaliva & Vamvakaki, 
2020). The X-ray diffraction peak is produced 
by the constructive interference of a 
monochromatic X-ray beam scattered at a 
certain angle from each set of lattice planes in 
the sample. The peak intensity is determined 
by the distribution of the atoms in the lattice. 
Consequently, the X-ray diffraction pattern is 
a fingerprint of the periodic arrangement of 
atoms in a given material (Bunaciu, 
Udriştioiu, & Aboul-Enein, 2015). 
SEM is used to analyze the shape of 
cocrystals that are formed with a stronger 
magnification than optical microscopes so 
that they can be observed down to the size of 
a micrometer. Observations using SEM 
provide visual information about the 
formation of cocrystals compared to their 
constituent materials. Based on the figure 2, 
the 1:2 ratio cocrystals are shaped like long 
blocks and large and small chunks with 
varying shapes and sizes. Different crystalline 
phases of solid particles usually exhibit 
different crystal habits (Zaini et al., 2020). 
Crystal habit can affect bulk particle 
properties such as powder flow properties, 
bulk density, and cocrystal compressibility 
(Rasenack et al., 2002). 
X-Ray Diffraction (XRD) 
Hydrochlorothiazide-para-amino benzoic 
acid cocrystals molar ratio 1:2 were also 
analyzed for their diffraction properties using 
X-Ray Diffraction (XRD). In the 1:2 ratio 
cocrystal diffractogram (see Figure 3.b), the 
diffractogram peaks appear at 2ɵ at about 
14.904o; 15.41o; 20,451o; 25.553o; 29.844o; 
 
Fig 2. Cocrystal hydrochlorothiazide – paraminobenzoic acid (1:2) with magnification a). 
500x and b) 200x 
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31.083o. The presence of these new peaks, 
especially the most obvious at 14.904o, 
indicates that a new crystalline phase 
(cocrystal) is formed (Panzade1, Shendarkar, 
Shaikh, & Rathi, 2017) because it does not 
appear on the diffractogram of the initial 
compound. From these results it can be stated 
that a new crystal is formed because of the 
interaction between hydrochlorothiazide and 
para-aminobenzoic acid.  
Differential Scanning Calorimetry 
The DSC instrument is used to observe 
and determine the thermal phenomenon of the 
sample due to temperature changes (Gill, 
Moghadam, & Ranjbar, 2010). The DSC 
method can be used as a screening tool to 
detect cocrystal formation in binary physical 
mixtures of drugs and their co-formers. This 
evidence assume that the melting point of the 
cocrystal is different from its constituent 
components (Schultheiss & Newman, 2009); 
(Saganowska & Wesolowski, 2018). Based 
on the DSC thermogram in Figure 4.a, an 
endothermic peak of hydrochlorothiazide was 
produced at 277.17oC and an exothermic peak 
at 315.67oC, where this endothermic peak 
indicated the melting point of 
hydrochlorothiazide while the appearance of 
an exothermic peak on the thermogram 
indicated that hydrochlorothiazide was 
decomposed. While the para-aminobenzoic 
acid thermogram (Figure 4.b) produced 2 
endothermic peaks at 196.43oC and 254.41oC. 
Based on the shape of the curve for para-
aminobenzoic acid, the second endothermic 
peak at 254.41oC does not indicate the 
melting point but the presence of the curve 
indicates that the para-aminobenzoic acid 
undergoes decomposition. However, it can be 
concluded that para-aminobenzoic acid has a 
melting point of 196.43oC.  
 
Fig 3. XRD Diffractogram of a) Hydrochlorothiazide, b) Cocrystal 1:2 
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Furthermore, the 1:2 ratio cocrystal 
thermogram (see Figure 4.c) shows 2 
endothermic peaks at 188.57oC and 353oC 
and one exothermic peak at 331oC. The 
endothermic peak correlates to the melting of 
the material (Steinmann et al., 2016), and the 
sharpest endothermic peak of cocrystal at 
188.57oC, which indicates the melting point 
of cocrystal. The exothermic peak indicates a 
change in the structure of the compound 
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which causes a decrease in enthalpy (Leyva-
Porras et al., 2020). The DSC profile 
indicates the occurrence of two main 
exothermic peaks, which represent the main 
components of cocrystal (Górska et al., 2020). 
The mixture of hydrochlorothiazide 
compounds with para-aminobenzoic acid 
which has different melting points decreased 
the melting point temperature to 188.57oC 
which indicates an interaction between the 
two compounds and the formation of a new 
phase. In accordance with Shanpui and Rajput 
(Sanphui & Rajput, Tuning solubility and 
stability of hydrochlorothiazide Co-crystals, 
2013) that the typical thermogram for 
hydrochlorothiazide cocrystals with para-
amino benzoic acid (1:2 solvent drop grinding 
method) is typical at the endothermic peak of 
175.9oC. 
Fourier Transform Infrared Spectroscopy 
Based on the results of the infrared 
spectrum, it can be seen that there is an 
interaction between hydrochlorothiazide and 
para-aminobenzoic acid which is indicated by 
a shift in the infrared wave number in the 
cocrystal spectrum with a ratio of 1:2. In the 
spectrum of hydrochlorothiazide (see Figure 
5.a), a sharp absorption band with strong 
intensity at 3361.93 cm-1 and 3265.48 cm-1 
indicates the presence of N-H (stretching). 
These two absorption bands in the cocrystal 
spectrum with a 1:2 ratio (see Figure 5.c) 
shifted to a higher wave number, namely at 
3410.15 cm-1 and 3356.14 cm-1. The shift in 
the wave number to a higher wave number 
indicates a hydrogen bond is formed (Sitorus, 
2009). 
Absorption band shifts also occur in the 
sulfonamide groups. The sulfonamide group 
is a triatomic molecule, in the infrared spectra 
there is always adjoining absorption for the 
frequency of symmetry and asymmetry 
(Sitorus, 2009). Wave number 1373.32 cm-1 
(asymmetric secondary sulfonamide) and 
1319.31 cm-1 (asymmetric primary 
sulfonamide) shifted to 1379.10 cm-1 
accompanied by an increase in absorption 
intensity and 1321.24 cm-1. The frequency of 
the symmetrical sulfonamide groups also 
shifted from 1151.50 cm-1 to 1172.72 cm-1. 
Furthermore, the para-aminobenzoic acid 
spectrum (see Figure 5.b) shows a sharp 
absorption band with medium intensity at of 
3230.77cm-1 experiencing a higher shift to 
3257.77 cm-1 at a cocrystal spectrum with a 
ratio of 1:2. The shift indicates an O-H shift 
(stretching). The absorption band shift also 
occurs in the N-H (stretching) spectrum of 
para-aminobenzoic acid from wave number 
3361.93 cm-1 to wave number 3410.15 cm-1 in 
the cocrystal spectrum ratio 1:2. The 
absorption band shift also occurs at C=O 
(stretching) in the para-aminobenzoic acid 
spectrum which shifts from 1662.64 cm-1 to 
1685.79 cm-1 in a cocrystal spectrum. 
The shifting of absorption peaks of FTIR 
spectra of hydrochlorothiazide-para-
aminobenzoic acid cocrystal indicated 
appearance intermolecular hydrogen bond 
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interactions between functional groups of 
hydrochlorothiazide and para-aminobenzoic 
acid (Wicaksono et al., 2019). Cocrystal 
results from the interaction of hydrogen 
 
 
Fig 5. FTIR spectra for a. Hydrochlorothiazide, b. para aminobenzoic acid; c. cocrystal (1:2) 
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bonds between the amine group of 
hydrochlorothiazide and the carboxylic group 
of para-amino benzoic acid, as indicated by 
the chemical shift of the sulfonamide groups 
from 1151.50 cm-1 to 1172.72 cm-1 and band 
shift of C=O (stretching) in the para-
aminobenzoic acid from 1662.64 cm-1 to 
1685.79 cm-1 in a cocrystal.  
CONCLUSION 
The hydrochlorothiazide-para-
aminobenzoic acid cocrystal has new 
crystalline peaks at 2θ of 14.904o; 15.41o; 
25.553o; 26.5o; 29.844o; 31.083o indicating 
the formation of a new crystalline phase. The 
cocrystal showed the melting point at 
188.57oC which is different from the initial 
components. The FTIR spectra of cocrystal 
showed the shifting of absorption peaks of 
groups of initial components indicating of 
formation of hydrochlorothiazide-para-
aminobenzoic acid cocrystal through 
intermolecular hydrogen bond interactions 
between amine/sulfonamide group and 
carboxyl group. 
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